Testing of antifungal combinations against yeasts and dermatophytes

Journal of Dermatological Treatment

Volumn 15, Issue 2, 2004, Pages 104-107

  Harman, S ^a   Ashbee, H R ^a,c   Evans, E G V ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Amorolfine; Dermatophyte; Synergy

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMATOPHYTE; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; YEAST;

EID: 1842663099     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630410025988     Document Type: Article

References (13)

1. Roberts DT, Evans EGV, Allen R, Fungal infections of the nail. Mosby-Wolfe: London, 1998: 88.
2. Evans EGV, Nail dermatophytosis: the nature and scale of the problem. J Dermatol Treat (1990) 1 (Suppl 2): 47-8.
3. Polak A, Combination of amorolfine with various antifungal drugs in dermatophytosis. Mycoses (1993) 36 (1-2): 43-9.
4. Meletiadis J, Mouton JW, Meis JF, Verweij PE, In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother (2003) 47: 106-17.
5. Perea S, Gonzalez G, Fothergill AW et al, In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother (2002) 46: 3039-41.
6. Evans EG, The rationale for combination therapy. Br J Dermatol (2001) 145 (Suppl 60): 9-13.
7. Baran R, Feuilhade M, Combernale P et al, A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J Dermatol (2000) 142: 1177-83.
8. Lecha M, Alsina M, Torres-Rodriguez JM et al, An open-label, multicenter study of the combination of amorolfine nail lacquer and oral itraconazole compared with oral itraconazole alone in the treatment of severe toenail onychomycosis. Curr Ther Res (2002) 63: 366-79.
9. Barchiesi F, Colombo AL, McGough DA, Rinaldi MG, Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the national committee for clinical laboratory standards' proposed standard. J Clin Microbiol (1994) 32: 2494-500.
10. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard M38-P. Villanova, PA: National Committee for Clinical Laboratory Standards, 1998.
11. Jessup CJ, Warner J, Isham N et al, Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol (2000) 38: 341-4.
12. Koneman EW, Allen SD, Janda PC et al, Antimicrobial susceptibility testing. In: Koneman EW, Allen SD, Janda WM, et al, eds. Diagnostic microbiology. Philadelphia, PA: Lippincott, 1992.
13. Marchetti O, Moreillon P, Glauser MP et al, Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother (2000) 44: 2373-81.